TAOP vs. MYSZ, BKYI, IFBD, BCAN, WAVD, ELYS, IDAI, OBLG, SYTA, and WORX
Should you be buying Taoping stock or one of its competitors? The main competitors of Taoping include My Size (MYSZ), BIO-key International (BKYI), Infobird (IFBD), BYND Cannasoft Enterprises (BCAN), WaveDancer (WAVD), Elys BMG Group (ELYS), T Stamp (IDAI), Oblong (OBLG), Siyata Mobile (SYTA), and SCWorx (WORX).
Taoping (NASDAQ:TAOP) and My Size (NASDAQ:MYSZ) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations.
Taoping has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Comparatively, My Size has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500.
Taoping has a net margin of 0.00% compared to My Size's net margin of -74.11%. Taoping's return on equity of 0.00% beat My Size's return on equity.
In the previous week, My Size had 1 more articles in the media than Taoping. MarketBeat recorded 2 mentions for My Size and 1 mentions for Taoping. Taoping's average media sentiment score of 0.00 beat My Size's score of -0.24 indicating that Taoping is being referred to more favorably in the media.
4.0% of Taoping shares are owned by institutional investors. Comparatively, 27.7% of My Size shares are owned by institutional investors. 45.4% of Taoping shares are owned by company insiders. Comparatively, 15.0% of My Size shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Taoping received 15 more outperform votes than My Size when rated by MarketBeat users. However, 73.68% of users gave My Size an outperform vote while only 54.72% of users gave Taoping an outperform vote.
Taoping has higher revenue and earnings than My Size.
My Size has a consensus price target of $12.00, indicating a potential upside of 179.72%. Given My Size's higher possible upside, analysts clearly believe My Size is more favorable than Taoping.
Summary
Taoping beats My Size on 8 of the 15 factors compared between the two stocks.
Get Taoping News Delivered to You Automatically
Sign up to receive the latest news and ratings for TAOP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TAOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
